James R. Berenson
Oncotherapeutics (United States)
ORCID: 0000-0003-1587-6104Also affiliated with Institute for Myeloma & Bone Cancer Research
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 2 papers. Top paper: “Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen”.
Tanya M. Spektor, Carley Turner, Alexa Cohen, Alberto Bessudo, Haresh Jhangiani +11 more
Kam C. Yeung, Michael A. Palladino, James R. Berenson, Benjamin Bonavida, Stavroula Baritaki